glp-1 agonists and pancreatitis Suspected drug-induced was rare but more common in patients taking than sulfonylureas, a recent analysis of a VA database finds glp 1 agonist side effects
Description
According to the latest Global Diabetes Map (10th edition) released by the International Diabetes Federation (IDF) in December 2021, the number of people aged 20 to 79 with diabetes worldwide was estimated at 537 million in 2021, with the number expected to grow to 700 million by 2045

It is going to be a stellar time for people practicing in this field.

Nat Microbiol
It is classified as a potent antioxidant with demonstrated effects on lipid metabolism, insulin sensitivity, and inflammation in both animal and human studies
Curr Opin Pharmacol
